LaFleur, Milling et al. perform an in vivo CRISPR screen of CD8+ T cells responding to tumors. They identify the E3 ubiquitin ligase STUB1 as a potent negative regulator of CD8+ T cell responses in tumors.
- Martin W. LaFleur
- Lauren E. Milling
- Arlene H. Sharpe